National Public Radio Continues to Examine Hospital Acquired Infections

Posted in These Categories: News of Hospital Acquired Infections

Medizone International, Inc. (Dually Traded: OTCBB/OTCQB: MZEI)
(http://medizoneint.com)

In the last month National Public Radio has looked at Hospital Acquired Infections on two different occasions. This subject is gaining tremendous media attention. On April 16, 2010, NPR: Talk of the Nation/Science Friday presented: Bacterial Infections Defy Treatment.

( http://www.npr.org/templates/rundowns/rundown.php?prgId=5&prgDate=04-16-2010 )

MRSA and C. diff. were the topic and the program discussed how hospital-acquired infection have moved into the community in general including prisons and athletic facilities.

I would invite you to listen to this most informative discussion between three of the most knowledgeable experts in the field.

The radio program included:

Stuart Levy who is a professor of molecular biology, microbiology and medicine at Tufts University. He’s also the president of the Alliance for the Prudent Use of Antibiotics and the author of “The Antibiotics Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers”

Maryn McKenna who is the author of “Superbug: The Fatal Menace of MRSA.” She’s also a contributing writer at the Center for Infectious Disease Research and Policy at the University of Minnesota.

Brad Spellberg who is an assistant professor of medicine at the Los Angeles Biomedical Research Center. That’s at Harbor-UCLA Medical Center. He’s also the author of “Rising Plague: The Global Threat from Deadly Bacteria and Our Dwindling Arsenal to Fight Them.”

They discussed bacteria that are resistant to every FDA-approved antibiotic.

I think one of the most enlightening segments is the explanation why there are really no drugs on the horizon to treat this issue.

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospitals, sports training facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures. Successful decontamination by AsepticSure™ to the 6 log standard or greater has been demonstrated with C.difficile, E coli, Pseudomonas aeruginous, MRSA, VRE and Bacillius subtilis.

Medizone International, Inc.
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Fax: 415-868-2344

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Share and Enjoy: